Pfizer Inc. et al v. Rubicon Research Private Ltd.
1:24-cv-00626 | Delaware District Court
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Upcoming Events | ||
---|---|---|
5 Months
| Joint Claim Construction Brief due by 9/5/2025. | Source Add |
6 Months
| Amended Pleadings due by 9/26/2025. Joinder of Parties due by 9/26/2025. | Source Add |
7 Months
| A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. | Source Add |
12 Months
| Fact Discovery completed by 3/25/2026. | Source Add |
18 Months
| Expert Discovery due by 9/24/2026. | Source Add |
Filing Date | # | Docket Text |
---|---|---|
9/30/2024 | Case associated with lead case: Create association to 1:24-cv-00621-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 24-621-CFC ONLY. (nmf) (Entered: 09/30/2024) | |
9/30/2024 | 21 | SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all future filings shall be made in Lead Case No. 24-621-CFC ONLY. Joinder of Parties due by 9/26/2025. Amended Pleadings due by 9/26/2025. Fact Discovery completed by 3/25/2026. Expert Discovery due by 9/24/2026. Joint Claim Construction Brief due by 9/5/2025. A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/15/2027. A Final Pretrial Conference is set for 2/8/2027 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/16/2027 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 09/30/2024) |
9/30/2024 | 20 | PROPOSED ORDER --[Proposed] Scheduling Order-- by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals, Pfizer Ireland Pharmaceutials. (Attachments: # 1 Letter to Judge Connolly)(Dellinger, Megan) (Entered: 09/30/2024) |
8/19/2024 | 19 | ANSWER to 14 Answer to Complaint, Counterclaim by Pfizer Inc., Pfizer Ireland Pharmaceuticals.(Dellinger, Megan) (Entered: 08/19/2024) |
8/12/2024 | 18 | Order Setting In-Person Scheduling Conference: A Scheduling Conference is set for 10/2/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 8/12/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 08/12/2024) |
8/8/2024 | 17 | Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding response to the Court's July 8, 2024 Order - re (20 in 1:24-cv-00621-CFC, 20 in 1:24-cv-00621-CFC, 12 in 1:24-cv-00625-CFC, 12 in 1:24-cv-00625-CFC, 13 in 1:24-cv-00626-CFC, 13 in 1:24-cv-00626-CFC, 12 in 1:24-cv-00623-CFC, 12 in 1:24-cv-00623-CFC, 13 in 1:24-cv-00627-CFC, 13 in 1:24-cv-00627-CFC, 12 in 1:24-cv-00624-CFC, 12 in 1:24-cv-00624-CFC, 13 in 1:24-cv-00622-CFC, 13 in 1:24-cv-00622-CFC) Order,, Set Deadlines,. (Dellinger, Megan) (Entered: 08/08/2024) |
8/5/2024 | 16 | NOTICE OF SERVICE of Defendant Rubicon Research Private Ltd.'s ANDA Production filed by Rubicon Research Private Ltd..(Dorsney, Kenneth) (Entered: 08/05/2024) |
7/30/2024 | Pro Hac Vice Attorney Joel L. Broussard for Pfizer Inc., Pfizer Ireland Pharmaceuticals, added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws) (Entered: 07/30/2024) | |
7/29/2024 | 15 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent General Atlantic Singapore RR Pte Ltd for Rubicon Research Private Ltd. filed by Rubicon Research Private Ltd.. (Dorsney, Kenneth) (Entered: 07/29/2024) |
7/29/2024 | 14 | ANSWER to 1 Complaint , COUNTERCLAIM against Pfizer Inc., Pfizer Ireland Pharmaceuticals by Rubicon Research Private Ltd..(Dorsney, Kenneth) (Entered: 07/29/2024) |
7/9/2024 | Pro Hac Vice Attorneys Jaimin H. Shah and Stephen R. Auten for Rubicon Research Private Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 07/09/2024) | |
7/8/2024 | 13 | ORDER: on or before August 9, 2024, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/ or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER Setting Deadlines: ( Notice of Compliance deadline set for 8/9/2024.) Signed by Judge Colm F. Connolly on 7/8/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 07/08/2024) |
7/3/2024 | SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten and Attorney Jaimin H. Shah filed by Rubicon Research Private Ltd. Signed by Judge Colm F. Connolly on 7/3/2024. (nmf) (Entered: 07/03/2024) | |
7/3/2024 | 12 | Pro Hac Vice Fee - Credit Card Payment received for Stephen R. Auten and Jaimin H. Shah. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten and Attorney Jaimin H. Shah )( Payment of $ 100, receipt number ADEDC-4444239).(Dorsney, Kenneth) (Entered: 07/03/2024) |
7/3/2024 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten and Attorney Jaimin H. Shah - filed by Rubicon Research Private Ltd.. (Dorsney, Kenneth) (Entered: 07/03/2024) |
6/4/2024 | 10 | WAIVER OF SERVICE returned executed by Pfizer Ireland Pharmaceuticals, Pfizer Inc.: For Rubicon Research Private Ltd. waiver sent on 5/29/2024, answer due 7/29/2024. (Dellinger, Megan) (Entered: 06/04/2024) |
5/31/2024 | Pro Hac Vice Attorney Dimitrios T. Drivas for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024) | |
5/31/2024 | Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024) | |
5/31/2024 | Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/31/2024) | |
5/30/2024 | SO ORDERED, re (8 in 1:24-cv-00626-CFC, 8 in 1:24-cv-00627-CFC, 10 in 1:24-cv-00625-CFC, 11 in 1:24-cv-00622-CFC, 9 in 1:24-cv-00623-CFC, 10 in 1:24-cv-00624-CFC, 9 in 1:24-cv-00621-CFC) MOTION for Pro Hac Vice Appearance of Attorneys Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceuticals. Ordered by Judge Colm F. Connolly on 5/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(kmd) (Entered: 05/30/2024) | |
5/30/2024 | 9 | Pro Hac Vice Fee - Credit Card Payment received for Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard )( Payment of $ 150, receipt number ADEDC-4419020).(Dellinger, Megan) (Entered: 05/30/2024) |
5/30/2024 | 8 | MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard - filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceutials. (Dellinger, Megan) (Entered: 05/30/2024) |
5/29/2024 | 7 | STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 05/29/2024) |
5/29/2024 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00621-CFC through 1:24-cv-00627-CFC (rjb) (Entered: 05/29/2024) | |
5/23/2024 | 6 | Summons Issued as to Rubicon Research Private Ltd. on 5/23/2024. (mrr) (Entered: 05/24/2024) |
5/23/2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Pfizer Ireland Pharmaceuticals filed by Pfizer Inc., Pfizer Ireland Pharmaceuticals. (mrr) (Entered: 05/24/2024) |
5/23/2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,083,724 B2. (mrr) (Entered: 05/24/2024) |
5/23/2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 04/12/2024. Date of Expiration of Patent: 03/25/2039.Thirty Month Stay Deadline: 8/27/2027. (mrr) (Entered: 05/24/2024) |
5/23/2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 05/24/2024) |
5/23/2024 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Rubicon Research Private Ltd. (Filing fee $ 405, receipt number ADEDC-4414653.) - filed by Pfizer Ireland Pharmaceuticals, Pfizer Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mrr) (Entered: 05/24/2024) |